RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eckert & Ziegler Stock

Eckert & Ziegler Stocks 2024

Eckert & Ziegler Stocks

20.82 M

Ticker

EUZ.DE

ISIN

DE0005659700

WKN

565970

In 2024, Eckert & Ziegler had 20.82 M outstanding stocks, a 0% change from the 20.82 M stocks in the previous year.

The Eckert & Ziegler Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2026e20.82
2025e20.82
2024e20.82
202320.82
202220.8
202120.75
202020.64
201920.53
201820.67
201721.15
201621.15
201521.15
20145.29
20135.3
20125.3
20115.3
20105.2
20093.8
20083.4
20073.6
20063.6
20053.6
20043.5

Eckert & Ziegler shares outstanding

The number of shares was Eckert & Ziegler in 2023 — This indicates how many shares 20.824 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eckert & Ziegler earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eckert & Ziegler's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eckert & Ziegler’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eckert & Ziegler's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eckert & Ziegler Aktienanalyse

What does Eckert & Ziegler do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Eckert & Ziegler's Shares Outstanding

Eckert & Ziegler's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Eckert & Ziegler’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Eckert & Ziegler’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Eckert & Ziegler’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Eckert & Ziegler stock

How many stocks are there of Eckert & Ziegler?

The current number of stocks of Eckert & Ziegler is 20.82 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Eckert & Ziegler are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Eckert & Ziegler evolved in recent years?

The number of shares of Eckert & Ziegler has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Eckert & Ziegler as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Eckert & Ziegler?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Eckert & Ziegler pay?

Over the past 12 months, Eckert & Ziegler paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.3 %. For the coming 12 months, Eckert & Ziegler is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler?

The current dividend yield of Eckert & Ziegler is 1.3 %.

When does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler?

Eckert & Ziegler paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.42 %.

In which sector is Eckert & Ziegler located?

Eckert & Ziegler is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler in the year 2023?

In the year 2023, Eckert & Ziegler distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler pay out the dividend?

The dividends of Eckert & Ziegler are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eckert & Ziegler stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eckert & Ziegler

Our stock analysis for Eckert & Ziegler Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.